Pfefferkorn, E R <br/><br/>
Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Jan 1994 
 - 31-7 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0066-4804 
<br/><br/><label>Standard No.: </label>10.1128/AAC.38.1.31  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Azithromycin--pharmacology<br/>Cells, Cultured<br/>Clindamycin--pharmacology<br/>Drug Resistance, Microbial<br/>Fibroblasts--microbiology<br/>Humans<br/>Leucine--metabolism<br/>Mutation<br/>Oxygen Consumption--drug effects<br/>Ribosomes--drug effects<br/>Spiramycin--pharmacology<br/>Toxoplasma--drug effects<br/>Uracil--metabolism